Scott Simon Tykodi

Dr. Scott Simon Tykodi is an Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and a faculty member at the Fred Hutch Cancer Center, specializing in kidney cancer and melanoma treatment through medical oncology.

Education:

• M.D. and Ph.D. from Washington University School of Medicine
• Residency in Internal Medicine at Barnes Jewish Hospital
• Fellowship in Medical Oncology and Hematology-Oncology at the University of Washington

Research Interests: Dr. Tykodi pioneers cancer immunotherapy translation, focusing on renal cell carcinoma and melanoma. His work develops novel immune-based therapeutics including cellular immunotherapy targeting the 5T4 antigen highly expressed on kidney cancer cells, with emphasis on bridging laboratory discoveries to clinical applications through rigorous trial design.

Clinical and Research Activities: Leading the Renal and Melanoma (Ren/Mel) Program at Fred Hutch, Dr. Tykodi coordinates multidisciplinary care integrating medical oncology, urology, and radiation oncology to accelerate treatment planning. His clinical trials portfolio drives immunotherapy standards forward, while his patient-centered philosophy prioritizes education as foundational to cancer care decision-making.